Adderall XR
information and resources from the National Cancer Institute
NCI Thesaurus | Adderall XR
(Other name for: dextroamphetamine-amphetamine)NCI Thesaurus | Adderall XR
(Other name for: dextroamphetamine-amphetamine)
|
|
|
|
news articles
Shire sues Teva over generic Adderall XR plans Mar 3, 2006
Reuters Teva Pharmaceuticals (TEVA.O: Quote, Profile, Research) over the Israeli drugmaker's plans to make a cheap, copycat version of hyperactivity drug Adderall XR. ...
Shire sues Teva over generic Adderall XR plans Mar 3, 2006
Scotsman, Shire Plc said on Friday it was suing Teva Pharmaceuticals over the Israeli drugmaker's plans to make a cheap, copycat version of hyperactivity drug Adderall XR ...
Shire blocks Teva's generic Adderall XR Mar 3, 2006
United Press International BASINGSTOKE, England, March 3 (UPI) -- Shire said Friday it filed a lawsuit in US federal court claiming Teva infringed upon Shire's patents on Adderall XR. ...
SHIRE PLC: ADDERALL XR(R) - THE COURT SETS OCTOBER 30, 2006 BENCH Mar 10, 2006
ITNews, PHILADELPHIA, Pennsylvania and BASINGSTOKE, England, March 10 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that in the pending ...
Shire sues Teva over generic Adderall XR plans Mar 3, 2006
Ely Times, ...it was suing Teva Pharmaceuticals (Nasdaq:TEVA - news) over the Israeli drugmaker‘s plans to make a cheap, copycat version of hyperactivity drug Adderall XR. ...
More Ways to Find Free Health Stuff for your Kids Mar 31, 2006
About - News & Issues, Concerta, Adderall XR, Ritalin LA and Focalin all offer coupons for new patients to get a free 4 week supply of their medication. ...
Shire, Cephalon ADHD Drugs Dangerous, Regulators Say (Update1) Mar 22, 2006
Bloomberg March 22 (Bloomberg) -- Shire Plc's Adderall XR for treating attention deficit disorder was linked to at least five heart-related deaths of children in a ...
FDA crosshairs on ADHD drugs Mar 21, 2006
CNNMoney.com Investors await panel's findings about the psychiatric and heart attack risks of Adderall XR and other ADHD drugs. By Aaron Smith, CNNMoney.com staff writer. ...
Label Changes Would Have Minimal Impact on ADHD Market Mar 28, 2006
PharmExec.com, Lisa Kelly, an analyst at Wood Mackenzie, noted that the market share of Adderall XR’s (amphetamine/dextroamphetamine) has not suffered since a warning for ...
ADHD drugs don't need `black box' warning, advisory panel says Mar 22, 2006
Kansas City Star, ...action. The drugs include Adderall XR, made by Shire PLC, and Concerta, made by McNeil Consumer & Specialty Pharmaceuticals. Provigil ...
Gauging risks of drugs for ADHD Mar 23, 2006
Philadelphia Inquirer, The drugs include Adderall XR, made by Shire PLC, whose US headquarters is in Wayne, and Concerta, made by McNeil Consumer & Specialty Pharmaceuticals, Fort ...
A Safe Stimulant? Mar 2, 2006
Forbes There has been no shortage of attention on Adderall XR, Shire Plc.’s popular stimulant used to calm and focus millions of children and adults with attention ...
FDA Hearing to Weigh Safety of ADHD Drugs Mar 22, 2006
Forbes Under consideration are all marketed drugs for ADHD, including amphetamines (Adderall XR), methylphenidates (Ritalin, Concerta and Metadate) and the non ...
Analysis: Tougher warnings for ADHD drugs Mar 22, 2006
Middle East North Africa Financial Network, Suicide warnings for other drugs, including Ritalin, Concerta, and Adderall XR are not warranted at this time, the committee concluded. ...
Shire Sues Teva Over ADHD Drug Mar 3, 2006
Red Herring, ...lawsuit in the United States against Israel ’s Teva Pharmaceuticals over its intent to market a generic version of Shire’s hyperactivity drug, Adderall XR. ...
ADHD panel rejects tough drug warnings Mar 22, 2006
Washington Times, ADHD drugs include Novartis AG's Ritalin, the oldest such treatment; Shire Pharmaceutical Group PLC's Adderall XR; Johnson & Johnson's Concerta and Eli Lilly & ...
ADHD: FDA debates black box warnings Mar 24, 2006
Pharmaceutical Business Review ...relief, combined with generic competition to rival products, suggest Strattera will overtake Johnson & Johnson's Concerta and Shire's Adderall XR to become the ...
Euroshares outlook - higher on Wall St gains; M&A hopes, earnings ... Mar 22, 2006
Forbes Shire may get some support as dealers note US government advisors say its attention deficit disorder drug Adderall XR doesn't need a black box warning that ...
ADHD - Cash Cow For Pharma - Possible Lawsuits Involving Drugs ... Mar 19, 2006
Best Syndication, ...in February 2005, cardiovascular concerns raised in adverse event reports led Canadian health officials to suspend market authorization of Adderall XR for six ...
Heat intensifies on ADHD drugs Mar 21, 2006
Monsters and Critics.com, ...last month. The label for Adderall XR, the market-leading drug, warns that misuse can lead to cardiovascular side effects. Matthew ...
Shire hit by new drug warning from FDA Mar 16, 2006
Independent, ...have slapped another warning on drugs for attention deficit hyperactivity disorder (ADHD), including Shire Pharmaceuticals' top-selling Adderall XR drug. ...
FDA Recommends Strong Warning Labels On the ADHD Drugs Mar 18, 2006
MedIndia, Shire Pharmaceuticals' top-selling Adderall XR drug for attention deficit hyperactivity disorder (ADHD) needs to carry stronger warnings about the risk of side ...
FDA Calls for Improved Warnings for ADD Drugs Mar 22, 2006
Los Angeles Times, ...medications. Medications for attention deficit-hyperactivity disorder include Ritalin, Adderall XR, Concerta, and some generics. ...
ADHD: stronger words of warning Mar 23, 2006
Seattle Times, But they said children with heart problems should not take the medications. ADHD medications include Ritalin, Adderall XR, Concerta and some generics. ...
Feds alarmed by psychosis in kids Mar 23, 2006
New York Daily News, And at least five kids on Adderall XR - one of the most prescribed ADHD drugs - have died from possible heart failure since it was approved for pediatric use ...
FDA panel urges strong warning on ADHD drugs Mar 23, 2006
San Francisco Chronicle, They said children with heart problems should not take the medications. Medications for ADHD include Ritalin, Adderall XR, Concerta, and some generics. ...
FTSE back over 6,000 as Tesco gains Mar 24, 2006
Reuters.uk, ...rival Cephalon should not be approved. Shire's top-selling Adderall XR medicine also treats hyperactivity disorder. By 8:19 am, the ...
FTSE extends gains above 6,000 Mar 23, 2006
Reuters.uk, ...experts stopped short of recommending the strongest possible warning on labels of attention deficit drugs, including Shire's blockbuster treatment, Adderall XR ...
More ADHD Drug Dangers Mar 22, 2006
KELOLAND TV, The drugs being looked at are all marketed for ADHD, including: Adderall XR, Ritalin, Concerta, Metadate and the non-stimulant Strattera. ...
Warnings to be toughened on ADHD drugs Mar 23, 2006
Fort Frances Times, 2005. And use of the drugs is increasing. Health Canada briefly pulled the ADHD drug Adderall XR from the market last year. CBC ...
Carnival, Kiln, Morrison, Next: UK, Irish Equity Preview Mar 22, 2006
Bloomberg Plc (SHP LN): Shares of the drugmaker may be active after US government advisers said drugs for attention deficit disorder such as Shire's Adderall XR don't ...
UK Stocks Decline, Led by William Morrison, Retail Shares Mar 23, 2006
Bloomberg US government advisers said drugs for attention deficit disorder such as Shire's Adderall XR don't need the strictest level of warnings for children because ...
Reviewing ADHD Drugs: FDA Goes Through the Motions Mar 24, 2006
Dissident Voice, The drugs under review include Ritalin from Novartis, Adderall and Adderall XR from Shire Pharmaceuticals, Concerta from Johnson & Johnson, and generic ...
UK Stocks Rise, Led by Land, Property Shares; Elan Declines Mar 22, 2006
Bloomberg US regulators said at least five children died from possible heart failure while taking Shire's Adderall XR in the year following the product's October 2004 ...
FTSE 100 reclaims 6,000 as Tesco climbs Mar 24, 2006
Financial Times, ...the US Food and Drug Administration said attention-deficit disorder drug Sparlon from Cephalon, a potential competitor drug to Shire’s Adderall XR, had not ...
Footsie kicks at barriers to strong performance Mar 24, 2006
Scotsman, Cephalon should not be approved. Shire's top-selling Adderall XR medicine also treats hyperactivity disorder. And oil giant BP ticked ...
London shares above 6,000 level midafternoon on insurers, positive ... Mar 17, 2006
Forbes ...was another casualty amid on-going fears US regulators may insist on stronger warnings on attention deficit hyperactivity disorder drugs such as its Adderall XR ...
Shire, Tesco help FTSE 100 back over 6,000 barrier Mar 24, 2006
Reuters.uk, Research) should not be approved. Shire's top-selling Adderall XR medicine also treats hyperactivity disorder. By 0819 GMT the FTSE ...
BA helps London higher Mar 23, 2006
Financial Times, The FDA concluded that further ‘black box’ warning labels were not necessary on the drugs, which include Shire’s Adderall XR. ...
Attention Deficit Hyperactivity Disorder - Just What Kids Need ... Mar 22, 2006
Best Syndication, ...from FDA official Andrew Mosholder, noted that psychosis/mania events occurred during double-blind treatment with every ADHD drug studied except Adderall XR. ...
AD/HD support programs on agenda Mar 23, 2006
Ottawa Sun, ...warnings. Health Canada pulled AD/HD drug Adderall XR off the market in 2005, after reports the drug was linked to 20 deaths worldwide. ...
New Warnings Urged for ADHD Drugs Mar 23, 2006
WebMD The committee concluded that further suicide warnings for stimulant drugs, including Ritalin, Concerta, and Adderall XR, are not warranted at this time. ...
Just What Kids Need - Sparlon - Another ADHD Drug Mar 19, 2006
OpEdNews ...from FDA official Andrew Mosholder, noted that psychosis/mania events occurred during double-blind treatment with every ADHD drug studied except Adderall XR.
London shares lose grip despite closing above 6000 Mar 23, 2006
Edinburgh Evening News, ...cent after a panel of pediatric experts stopped short of recommending the strongest possible warning on labels of attention-deficit drugs, including Adderall XR ...
Cable Drips Lower Mar 23, 2006
Daily FX, ...gained 3.3% to 915½p on news of a decision that further ‘black box’ warning labels were not necessary on the drugs, which include Shire’s Adderall XR. ...
Stronger alerts on ADHD drugs urged Mar 23, 2006
Kansas City Star, ...those in the general population. Medications for ADHD include Ritalin, Adderall XR, Concerta and some generics. It was unclear how ...
Shire Sues Teva Pharmaceutical Industries Ltd. and Teva ... Mar 3, 2006
PR Newswire (press release), ...results from an Abbreviated New Drug Application filed by Teva for generic versions of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg ADDERALL XR(R), pursuant to ...
FTSE buoyed by UK retailers, oil companies Mar 24, 2006
Investor's Business Daily (subscription) Shire, which makes a rival ADHD product -- Adderall XR -- gained 2%. In the mining sector, copper miner Antofagasta (ANTOANTO) added 1.45%. ...
Shire begins Teva legal proceedings Mar 3, 2006
ShareCast, ...said it has filed a lawsuit in the US District Court for the Eastern District of Pennsylvania against Teva for infringement of its US patents for Adderall XR. ...
Stimulating debate over drugs Mar 14, 2006
Times Online, ...problems and strokes. In Canada, health concerns led to the temporary suspension of sales of Adderall XR last year. However, US ...
Shire sues Teva for alleged patent infringement Mar 3, 2006
Forbes A statement from Shire said the lawsuit results from an Abbreviated New Drug Application filed by Teva for generic versions of Adderall XR, Shire's Attention ...
Shire sues Teva Pharmaceutical Industries Ltd. and Teva ... Mar 6, 2006
Chemie.de (press release), ...from an Abbreviated New Drug Application filed by Teva for generic versions of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg ADDERALL XR®, Shire's Attention ...
ADDERALL XR(R) - FURTHER FINAL PRETRIAL CONFERENCE SET FOR MARCH ... Dec 11, 2005
ITNews, BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, December 12 /PRNewswire/ -- Shire plc (LSE: SHP ; NASDAQ: SHPGY ; TSX: SHQ) announces that in the pending ...
ADDERALL XR(R) - Further Final Pretrial Conference Set for March ... Dec 11, 2005
Yahoo! News (press release) BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, December 12 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP - News; NASDAQ: SHPGY - News; TSX: SHQ - News ...
ADDERALL XR - Further Final Pretrial Conference Set for March 10 ... Dec 12, 2005
PharmaLive.com (press release), BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, December 12, 2005 /PRNewswire-FirstCall/ -- Shire plc announces that in the pending New York litigation ...
ADDERALL XR - Further Final Pretrial Conference Set For March 10 ... Dec 12, 2005
PharmaLive.com (press release), BASINGSTOKE, England, and PHILADELPHIA, December 12, 2005 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that in the pending New York litigation ...
CSFB Lifts Shire Price Target >SHPGY Dec 6, 2005
New Ratings ...results, we are becoming increasingly optimistic that either a settlement (with Barr Labs) or a delay to the launch of generic versions of Adderall XR (vs our ...
(PRN) - Revolutionary Performance Technique Seeks to Create ' ... Dec 11, 2005
Bolsamania.com, ...(PRN) - ADDERALL XR(R) - Further Final Pretrial Conference Set for March 10, 2006. No Trial Date Set ... [+. PRN) - Century Casinos ...
Speeding past test stress Dec 11, 2005
Daily Iowan (subscription), Mikan realizes an exam is fast approaching, she says the stress can often become overbearing - unless she can find a tiny blue capsule marked "Adderall XR 30mg ...
Students turn to Adderall to get by Dec 4, 2005
The Daily Campus Adderall XR “is unique in that it contains two types of drug beads designed to give double-pulsed delivery of amphetamines, intensifying the effect and ...
Shire Filing; Key Milestone -Collins Stewart Dec 8, 2005
New Ratings Notes this product is the company's back-up in case its Adderall XR drug does face generic competition in the future, and has the potential to grow the market ...
ADHD patch faces tough time at FDA panel meeting Dec 2, 2005
Pharma Times (subscription), Daytrana is one of six new products Shire is hoping to launch next year to help it weather the loss of marketing exclusivity on Adderall XR (mixed amphetamine ...
Company asks FDA for approval of new drug Dec 7, 2005
Roanoke Times, New River said last May that the 2004 market for drugs of this kind in the US was $1.5 billion. The recent market leader was Shire's Adderall XR. ...
Shire Pharmaceuticals "hold" Dec 6, 2005
New Ratings ...acquisition of TKT and the in-licensing of NRP104, in order to address the competitive threat posed by Barr Pharmaceutical’s generic version of Adderall XR. ...
Panel tells FDA to reject Shire/Noven ADHD patch for kids Dec 1, 2005
Philadelphia Business Journal, Shire, which is based in London and has its US headquarters in Wayne, Pa., has two ADHD drugs already in the market: Adderall and Adderall XR.
Noven/Shire: a patch in the balance Dec 2, 2005
Pharmaceutical Business Review While the effect on Shire's revenues would not be great, approval could help cushion the blow that the company's top-selling ADHD drug Adderall XR could face ...
|
|
